OVAC Sign-On Statement on Recent Executive Actions That Threaten Progress

As members of organizations unified in our support for the life-saving power of cancer research, we oppose recent executive actions that indisputably jeopardize progress in the fight against cancer today and for years to come.

Cuts to our nation's health and research infrastructure funding and widespread layoffs at the National Institutes of Health, including the National Cancer Institute, the Centers for Disease Control and Prevention, and the Food and Drug Administration will have a devastating impact on the more than 2 million people who will be diagnosed with cancer this year alone. The negative impact of cuts will be felt across the country where research generates significant economic activity and jobs in every state. The United States also risks losing its global competitive edge in biomedical research as these actions threaten to halt or end clinical trials, shutter sophisticated medical labs across the country, force young researchers to reconsider or abandon academic research and jeopardize Americans' access to the latest and best medical advancements, including new cancer treatments, for years to come.

We stand ready as a community to work with the administration and Congress to ensure we continue the progress that has driven a 34% reduction in cancer mortality over the past two decades. We call on the administration to stand with patients, researchers, caregivers, physicians, pharmacists, and nurses by reversing these harmful actions and continuing our nation's longstanding bipartisan support for cancer research and prevention.

Sincerely,

National Organizations (33)

  • American Association for Cancer Research
  • American Cancer Society Cancer Action Network
  • American Society for Radiation Oncology
  • Asbestos Disease Awareness Organization (ADAO)
  • Association of American Cancer Institutes
  • Children's Cancer Cause
  • Deadliest Cancers Coalition
  • Debbie's Dream Foundation: Curing Stomach Cancer
  • ECAN Esophageal Cancer Action Network
  • Fight Colorectal Cancer
  • Friends of Cancer Research
  • Global Liver Institute
  • GO2 for Lung Cancer
  • Head for the Cure Foundation
  • Hematology/Oncology Pharmacy Association
  • International Myeloma Foundation
  • LIVESTRONG
  • LUNGevity Foundation
  • Melanoma Research Foundation
  • METAvivor
  • National Brain Tumor Society
  • National Cancer Registrars Association
  • Oncology Nursing Society
  • Ovarian Cancer Research Alliance
  • Pancreatic Cancer Action Network (PanCAN)
  • Patient Empowerment Network
  • Pennsylvania Prostate Cancer Coalition
  • Society for Immunotherapy of Cancer
  • Society Gynecologic Oncology
  • The Leukemia & Lymphoma Society
  • The National Alliance of State Prostate Cancer Coalitions
  • The National Pancreas Foundation
CanerBuddy app
Advocacy Collaborations

HOPA, Bone Marrow & Cancer Foundation, and Walgreens Specialty Unite to Provide Oncology Pharmacy Education

HOPA, the Bone Marrow & Cancer Foundation (BMCF), and Walgreens Specialty Pharmacy have partnered on digital outreach resources and tools to support patients who are navigating the complexities of cancer treatment.

Advocacy

HOPA and CMRignite Launch "Time to Talk Diversity in Clinical Trials" Campaign

HOPA and CMRignite have collaborated on "Time to Talk Diversity in Clinical Trials," a campaign to address the critical need for increased diversity in cancer clinical research and ensure that all patient populations are adequately represented.

Advocacy

Pharmacists & Patients Lend Their Voices to Virtual Hill Day

HOPA members, patients, and caregivers participated in a total of 80 meetings with representatives from 31 states.